In the current study, we describe a novel mechanism of metformin in preventing CRC tumor development by which metformin inhibited LCA-induced IL-8 upregulation in HCT116 CRC cells and obstructed the proliferation and tubelike formation of ECV304 endothelial cells. Here, CXCL8 is linked to neoplasm.